This opinion piece looks at while HPV vaccines have been approved for females over 26, they are not currently granted access to this through the NHS. Richie argues that we must close this vaccination gap.
Get full access to this article
View all access options for this article.
References
1.
RichieC. Sex, not gender. A plea for accuracy. Exp Mol Med2019;51(11):1.
Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep2010;59(20):630–2. Available online at: https://www.cdc.gov/mmwr/preview/mmwrhtml/mm5920a5.htm (last accessed 24 June 2023).
4.
MaldonadoIPlataMGonzalezM, et al. Effectiveness, immunogenicity, and safety of the quadrivalent HPV vaccine in women and men aged 27–45 years. Hum Vaccin Immunother2022;18(5):2078626.
5.
ArbynMWeiderpassEBruniL, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health2020;8(2):e191–203.
6.
OkunadeKS. Human papillomavirus and cervical cancer. J Obstet Gynaecol2020;40(5):602–8.
AndersenBChristensenBSChristensenJ, et al. HPV-prevalence in elderly women in Denmark. Gynecol Oncol2019;154(1):118–23.
10.
AdeliMMoghaddam-BanaemLShahaliS. Sexual dysfunction in women with genital warts: a systematic review. BMC Women’s Health2022;22(1):1–14.
11.
ZouZFairleyCKOngJJ, et al. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Health2020;8(10):e1335–44.
12.
MarkowitzLEGeeJChessonH, et al. Ten years of human papillomavirus vaccination in the United States. Acad Pediatr2018;18(2S):S3–10 (Table 2).
13.
CameronRLKavanaghKPanJ, et al. Human papillomavirus prevalence and herd immunity after introduction of vaccination program, Scotland, 2009–2013. Emerg Infect Dis2016;22(1):56–64.
14.
FalcaroMCastañonANdlelaB, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet2021;398(10316):2084–92.
15.
KeddyKHRachmawatiT. Herd immunity or health equity?—Extending HPV vaccination. Lancet Reg Health West Pac2023;36:100793.
